Evidence map›Paper›PMID 34643933›Full record

ArticleHuman cell2022

The difference in the intracellular Arg/Lys-rich and EHLVY motifs contributes to distinct subcellular distribution of HAI-1 versus HAI-2.

Nanxi Huang, Robert B Barndt, Dajun D Lu, Qiaochu Wang, Shih-Ming Huang, Jehng-Kang Wang, Ping-Ying Chang, Chao-Yang Chen, Je-Ming Hu, Hui-Chen Su and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Human cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Nanxi HuangLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, W412, W416 Research Building 3970 Reservoir Road NW, Washington, DC, 20057, USA.
Robert B BarndtLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, W412, W416 Research Building 3970 Reservoir Road NW, Washington, DC, 20057, USA.
Dajun D LuLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, W412, W416 Research Building 3970 Reservoir Road NW, Washington, DC, 20057, USA.
Qiaochu WangLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, W412, W416 Research Building 3970 Reservoir Road NW, Washington, DC, 20057, USA.
Shih-Ming HuangDepartment of Biochemistry, National Defense Medical Center, Taipei, 114, Taiwan, ROC.
Jehng-Kang WangDepartment of Biochemistry, National Defense Medical Center, Taipei, 114, Taiwan, ROC.
Ping-Ying ChangDivision of Hematology/Oncology, Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan, ROC.
Chao-Yang ChenSchool of Medicine, National Defense Medical Center, Taipei, Taiwan, ROC.
Je-Ming HuSchool of Medicine, National Defense Medical Center, Taipei, Taiwan, ROC.
Hui-Chen SuDepartment of Pharmacy, Chi-Mei Medical Center, Tainan, Taiwan, ROC. Michael.maggil@gmail.com.
Michael D JohnsonLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, W412, W416 Research Building 3970 Reservoir Road NW, Washington, DC, 20057, USA. johnsom@georgetown.edu.
Chen-Yong LinLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, W412, W416 Research Building 3970 Reservoir Road NW, Washington, DC, 20057, USA. lincy@georgetown.edu.ORCID http://orcid.org/0000-0002-6391-2571
Georgetown University · USTri-Service General Hospital · TWNational Defense Medical Center · TWChi Mei Medical Center · TW

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI Louis M Weiner · 1990 to 2026
$71.5M
Mechanisms of Deregulation of Matriptase in Breast CancerR01CA123223 · NCI · GEORGETOWN UNIVERSITY · PI JOHNSON, MICHAEL D, LIN, CHEN-YONG · 2010 to 2014
$1.6M
chi mei medical center CMNDMC10807chi mei medical center CMNDMC10905ministry of national defense medical affairs bureau MND-MAB-110-045NCI NIH HHS P30-CA051008NCI NIH HHS R01 CA 123223
6 · The paper itself

Abstract

The integral membrane, Kunitz-type, serine protease inhibitors, HAI-1 and HAI-2, closely resemble one another structurally and with regard to their specificity and potency against proteases. Structural complementarity between the Kunitz domains and serine protease domains renders the membrane-associated serine proteases, matriptase and prostasin, the primary target proteases of the HAIs. The shared biochemical enzyme-inhibitor relationships are, however, at odds with their behavior at the cellular level, where HAI-1 appears to be the default inhibitor of these proteases and HAI-2 a cell-type-selective inhibitor, even though they are widely co-expressed. The limited motility of these proteins caused by their membrane anchorages may require their co-localization within a certain distance to allow the establishment of a cellular level functional relationship between the proteases and the inhibitors. The differences in their subcellular localization with HAI-1 both inside the cell and on the cell surface, compared to HAI-2 predominately in intracellular granules has, therefore, been implicated in the differential manner of their control of matriptase and prostasin proteolysis. The targeting signals present in the intracellular domains of the HAIs are systematically investigated herein. Studies involving domain swap and point mutation, in combination with immunocytochemistry and cell surface biotinylation/avidin depletion, reveal that the different subcellular localization between the HAIs can largely be attributed to differences in the intracellular Arg/Lys-rich and EHLVY motifs. These intrinsic differences in the targeting signal render the HAIs as two independent rather than redundant proteolysis regulators.

Indexed as

Amino Acid MotifsArginineAvidinBiotinylationCell MembraneCells, CulturedCytoplasmic GranulesHumansIntracellular SpaceLysineMembrane GlycoproteinsProstasinProteinase Inhibitory Proteins, SecretoryProtein DomainsProteolysisSerine EndopeptidasesArginineAvidinLysinematriptaseMembrane GlycoproteinsProstasinProteinase Inhibitory Proteins, SecretorySerine EndopeptidasesSPINT1 protein, humanSPINT2 protein, humanHAI-1HAI-2Subcellular targeting signals

Identifiers

PMID34643933
OpenAlexW3206021521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.